Literature DB >> 15615643

Transgenic animal models of tauopathies.

Virginia M-Y Lee1, Theresa K Kenyon, John Q Trojanowski.   

Abstract

Tauopathies are a group of neurodegenerative disorders that include Alzheimer's disease, frontotemporal dementia with parkinsonism linked to chromosome 17 (FTDP-17) and other related diseases with prominent tau pathology. Research advances in the last several decades have characterized and defined tau neuropathologies of both neuron and glia in these diverse disorders and this has stimulated development of animal models of tauopathies. Indeed, animal models ranging from invertebrate species such as C. elegan to Drosophila melanogaster and mammalian transgenic mouse models of tauopathies have been generated and reported. This review summarizes the salient features of many of the known models of tauopathies.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15615643     DOI: 10.1016/j.bbadis.2004.06.014

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  48 in total

1.  Characterization of tau fibrillization in vitro.

Authors:  Shaohua Xu; Kurt R Brunden; John Q Trojanowski; Virginia M-Y Lee
Journal:  Alzheimers Dement       Date:  2010-03       Impact factor: 21.566

2.  Rous-Whipple Award Lecture. The Alzheimer's brain: finding out what's broken tells us how to fix it.

Authors:  John Q Trojanowski; Virginia M-Y Lee
Journal:  Am J Pathol       Date:  2005-11       Impact factor: 4.307

Review 3.  Boom and bust: a review of the physiology of the marsupial genus Antechinus.

Authors:  R Naylor; S J Richardson; B M McAllan
Journal:  J Comp Physiol B       Date:  2008-01-22       Impact factor: 2.200

Review 4.  Murine models of Alzheimer's disease and their use in developing immunotherapies.

Authors:  Thomas Wisniewski; Einar M Sigurdsson
Journal:  Biochim Biophys Acta       Date:  2010-05-13

5.  Age-associated cerebral atrophy in mouse lemur primates.

Authors:  Audrey Kraska; Olene Dorieux; Jean-Luc Picq; Fanny Petit; Emmanuel Bourrin; Evelyne Chenu; Andreas Volk; Martine Perret; Philippe Hantraye; Nadine Mestre-Frances; Fabienne Aujard; Marc Dhenain
Journal:  Neurobiol Aging       Date:  2009-06-28       Impact factor: 4.673

6.  Identification of aminothienopyridazine inhibitors of tau assembly by quantitative high-throughput screening.

Authors:  Alex Crowe; Wenwei Huang; Carlo Ballatore; Ronald L Johnson; Anne-Marie L Hogan; Ruili Huang; Jennifer Wichterman; Joshua McCoy; Donna Huryn; Douglas S Auld; Amos B Smith; James Inglese; John Q Trojanowski; Christopher P Austin; Kurt R Brunden; Virginia M-Y Lee
Journal:  Biochemistry       Date:  2009-08-18       Impact factor: 3.162

Review 7.  Versatile somatic gene transfer for modeling neurodegenerative diseases.

Authors:  Ronald L Klein; David B Wang; Michael A King
Journal:  Neurotox Res       Date:  2009-08-11       Impact factor: 3.911

Review 8.  Immunotherapeutic approaches for Alzheimer's disease in transgenic mouse models.

Authors:  Thomas Wisniewski; Allal Boutajangout
Journal:  Brain Struct Funct       Date:  2009-12-10       Impact factor: 3.270

9.  Tau expression levels from various adeno-associated virus vector serotypes produce graded neurodegenerative disease states.

Authors:  Ronald L Klein; Robert D Dayton; Jason B Tatom; Cynthia G Diaczynsky; Michael F Salvatore
Journal:  Eur J Neurosci       Date:  2008-04       Impact factor: 3.386

Review 10.  Transgenic Drosophila models of Alzheimer's disease and tauopathies.

Authors:  Kanae Iijima-Ando; Koichi Iijima
Journal:  Brain Struct Funct       Date:  2009-12-05       Impact factor: 3.270

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.